Navigation Links
Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
Date:11/12/2009

or the Nine Months For the Three Months Ended September 30, Ended September 30, 2009 2008 2009 2008 ---- ---- ---- ---- Revenues $- $- $- $- Operating costs and expenses: Research and development 850,998 2,451,579 4,549,883 5,438,082 General and administrative 441,316 463,199 1,555,786 1,664,405 ----------- ------------ ------------ ------------ Total operating costs and expenses 1,292,314 2,914,778 6,105,669 7,102,487 ----------- ------------ ------------ ------------ Loss from operations (1,292,314) (2,914,778) (6,105,669) (7,102,487) Interest income 5,594 59,418 25,861 285,640 ----------- ------------ ------------ ------------ Loss before income taxes (1,286,720) (2,855,360) (6,079,808) (6,816,847) Provision for income taxes - - - - ----------- ------------ ------------ ------------ Net loss $(1,286,720) $(2,855,360) $(6,079,808) $(6,816,847) =========== ============ ============ ============ Loss per share - basic and diluted $(0.09) $(0.22) $(0.43) $(0.54) =========== ============ ============ ============ Weighted average shares outstanding - basic and diluted 14,065,385 12,863,196 14,065,385 12,661,859 =========== ============ ============ ============
                         CATALYST PHARMACEUTI
'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
5. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
6. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
7. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
8. Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
9. Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering
10. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
11. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... 17 The following letter is being released ... , Dear Fellow Shareholders: , We are pleased to report to you ... ever. During this difficult time we were able to complete and validate ... being able to manufacture Multikine for the Phase III clinical trial.  We ...
... , RALEIGH, N.C. , Feb. ... training solutions for the pharmaceutical and biotech industry, today announced ... and Retail Pharmacy .  The courses, developed in partnership ... to the company,s Managed Markets Excellence® Series, a ...
Cached Medicine Technology:CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5CEL-SCI Corporation Releases Letter to Shareholders 6Pharmaceutical Institute Launches New Training Resources Focused on Employers and Retail Pharmacy 2Pharmaceutical Institute Launches New Training Resources Focused on Employers and Retail Pharmacy 3
(Date:7/9/2014)... -- Researchers from The Miriam Hospital have found ... who are also depressed have difficulty sticking to ... particularly true for women, and screening and brief ... of treatment. The study and its findings are ... , Chronic obstructive pulmonary disease is a ...
(Date:7/9/2014)... world have been linked to an emerging fungal ... National Institute for Mathematical and Biological Synthesis (NIMBioS) ... , In a series of mathematical models, ... of internal organs in frogs, could cause extinction ... are exposed to the virus every few years, ...
(Date:7/9/2014)... A retrospective study conducted by researchers at Tufts University ... adults with intellectual and developmental disabilities, the likelihood of ... dental care increased. The findings, published in the July/August ... help improve interventions designed to address the oral health ... reviewed the dental records of 107 patients at one ...
(Date:7/9/2014)... dramatically in Western societies. One frequently cited reason is ... fewer infections than previous generations, thereby delaying maturation of ... Sahlgrenska Academy, University of Gothenburg, monitored children until the ... system in relation to allergic disease. All of the ... Region, half of them on farms that produced milk.,Lower ...
(Date:7/8/2014)... A team of clinicians from Plymouth, UK, and Sydney, ... 10th July Australia) launched ACEmobile - a free-to-use app ... , ACEmobile is the first of its kind; an ... tool provides support through the whole process, meaning more ... out this type of assessment. Designed by clinicians for ...
Breaking Medicine News(10 mins):Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:New app widens opportunities for dementia assessments 2Health News:New app widens opportunities for dementia assessments 3
... Oct. 15 With the Centers for Disease Control and ... now spread throughout the United States, the American Red Cross ... or are taking care of someone who has the flu. ... person to person in droplets of coughs or sneezes, and ...
... 15 Americans without health insurance are one major illness ... research by the Kellogg School of Management at Northwestern University ... major health concern, such as heart disease, cancer or a ... in order to pay their medical expenses. , ...
... a Medical College of Georgia resident and faculty member may ... circumstances. About 2 percent of patients that undergo the ... performed in an emergency situation or prior to surgery. ... and uses a metal scope to open the mouth and ...
... Smoking bans are effective at reducing the risk of ... secondhand smoke, says a new report from the Institute ... sufficient evidence that breathing secondhand smoke boosts nonsmokers, risk ... even relatively brief exposures could lead to a heart ...
... Past President of the New Jersey Obstetrical and Gynecological Society ... 15 According to NAMS (North American Menopause Society), 6,000 ... a year. For the majority of women, hot flashes, ... For years, women have searched for a treatment that ...
... beautifully clear, acne-free skin, naturally? Skip the synthetics and ... Bees(®) Natural Acne Solutions(TM) products. , To view the ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091015/NY92770 ) ... truly natural* acne line clinically proven to help ...
Cached Medicine News:Health News:Red Cross Offers Important Tips for Caring for Someone With the Flu 2Health News:Red Cross Offers Important Tips for Caring for Someone With the Flu 3Health News:The Effects of Health on Wealth: New Study Reveals Individuals Without Health Insurance at Risk for 'Financial Catastrophe' 2Health News:The Effects of Health on Wealth: New Study Reveals Individuals Without Health Insurance at Risk for 'Financial Catastrophe' 3Health News:New laryngoscope could make difficult intubations easier 2Health News:Smoking bans reduce the risk of heart attacks associated with secondhand smoke 2Health News:On World Menopause Day, October 18, The International Menopause Society and World Health Organization Urge Women to Learn About Their Options for Dealing With Menopause 2Health News:On World Menopause Day, October 18, The International Menopause Society and World Health Organization Urge Women to Learn About Their Options for Dealing With Menopause 3Health News:Video: Introducing Natural Acne Solutions(TM) By Burt's Bees(R) 2
... The Aculens 186 UV combines the ... that include measurement of ultra violet transmission ... Velo 186 is also programmed to network ... other VELO Instruments, today, or in the ...
...
...
...
Medicine Products: